Sygnature Discovery Ltd

Royaume‑Uni

Retour au propriétaire

1-8 de 8 pour Sygnature Discovery Ltd Trier par
Recheche Texte
Affiner par
Type PI
        Marque 6
        Brevet 2
Juridiction
        International 4
        Canada 2
        États-Unis 2
Date
2024 novembre 2
2024 6
2022 1
2020 1
Classe IPC
C07D 311/24 - Benzo [b] pyrannes non hydrogénés dans le carbocycle avec des atomes d'oxygène ou de soufre liés directement en position 4 avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement en position 2 2
C07D 405/12 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons 2
C07D 405/14 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles 2
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux 1
A61P 35/00 - Agents anticancéreux 1
Voir plus
Classe NICE
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 6
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau 6
42 - Services scientifiques, technologiques et industriels, recherche et conception 6
Statut
En Instance 4
Enregistré / En vigueur 4

1.

SYGNATURE DISCOVERY

      
Numéro d'application 1825452
Statut Enregistrée
Date de dépôt 2024-09-27
Date d'enregistrement 2024-09-27
Propriétaire Sygnature Discovery Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

2.

SYGNATURE DISCOVERY

      
Numéro d'application 1823673
Statut Enregistrée
Date de dépôt 2024-09-12
Date d'enregistrement 2024-09-12
Propriétaire Sygnature Discovery Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

3.

SYGNATURE DISCOVERY

      
Numéro d'application 236512600
Statut En instance
Date de dépôt 2024-09-27
Propriétaire Sygnature Discovery Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. (1) Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. (2) Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

4.

SYGNATURE DISCOVERY

      
Numéro de série 79411026
Statut En instance
Date de dépôt 2024-09-27
Propriétaire Sygnature Discovery Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

5.

SYGNATURE DISCOVERY

      
Numéro de série 79410216
Statut En instance
Date de dépôt 2024-09-12
Propriétaire Sygnature Discovery Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

6.

SYGNATURE DISCOVERY

      
Numéro d'application 236347200
Statut En instance
Date de dépôt 2024-09-12
Propriétaire Sygnature Discovery Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. (1) Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. (2) Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

7.

MODULATORS OF THE INTEGRATED STRESS PATHWAY

      
Numéro d'application US2021057300
Numéro de publication 2022/094244
Statut Délivré - en vigueur
Date de dépôt 2021-10-29
Date de publication 2022-05-05
Propriétaire
  • CALICO LIFE SCIENCES LLC (USA)
  • ABBVIE INC. (USA)
  • SYGNATURE DISCOVERY LIMITED (Royaume‑Uni)
Inventeur(s)
  • Martin, Kathleen, Ann
  • Sidrauski, Carmela
  • Dart, Michael, J.
  • Murauski, Kathleen, J.
  • Randolph, John, T.
  • Shi, Lei
  • Smith, Russell, C.
  • Tong, Yunsong
  • Xu, Xiangdong
  • Benelkebir, Hanae
  • Chohan, Kamaldeep, K.
  • Edeson, Steven, J.
  • Schwenk, Sebastian
  • Starbuck, Kathryn, A.

Abrégé

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (I SR) and for treating related diseases, disorders, and conditions.

Classes IPC  ?

  • C07D 231/12 - Composés hétérocycliques contenant des cycles diazole-1, 2 ou diazole-1, 2 hydrogéné non condensés avec d'autres cycles comportant deux ou trois liaisons doubles entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques avec uniquement des atomes d'hydrogène, des radicaux hydrocarbonés ou des radicaux hydrocarbonés substitués, liés directement aux atomes de carbone du cycle
  • C07D 231/18 - Un atome d'oxygène ou de soufre
  • C07D 231/20 - Un atome d'oxygène lié en position 3 ou 5
  • C07D 231/56 - BenzopyrazolesBenzopyrazoles hydrogénés
  • C07D 311/24 - Benzo [b] pyrannes non hydrogénés dans le carbocycle avec des atomes d'oxygène ou de soufre liés directement en position 4 avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement en position 2
  • C07D 405/12 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 405/14 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
  • C07D 413/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes d'azote et d'oxygène comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 413/14 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes d'azote et d'oxygène comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
  • C07D 471/04 - Systèmes condensés en ortho
  • C07D 213/64 - Un atome d'oxygène lié en position 2 ou 6
  • C07D 249/04 - Triazoles-1, 2, 3Triazoles-1, 2, 3 hydrogénés
  • C07D 401/04 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une liaison directe de chaînon cyclique à chaînon cyclique
  • C07D 401/06 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une chaîne carbonée contenant uniquement des atomes de carbone aliphatiques
  • C07D 403/04 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une liaison directe de chaînon cyclique à chaînon cyclique

8.

SUBSTITUTED CYCLOLAKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY

      
Numéro d'application US2020030817
Numéro de publication 2020/223536
Statut Délivré - en vigueur
Date de dépôt 2020-04-30
Date de publication 2020-11-05
Propriétaire
  • CALICO LIFE SCIENCES LLC (USA)
  • ABBVIE INC. (USA)
  • SYGNATURE DISCOVERY LIMITED (Royaume‑Uni)
Inventeur(s)
  • Martin, Kathleen, Ann
  • Sidrauski, Carmela
  • Frost, Jennifer, M.
  • Tong, Yunsong
  • Xu, Xiangdong
  • Chung, Seungwon
  • Zhang, Qingwei, I.
  • Shi, Lei
  • Murauski, Kathleen, J.
  • Dart, Michael, J.
  • Randolph, John, T.
  • Benelkebir, Hanae

Abrégé

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.

Classes IPC  ?

  • C07D 265/36 - Oxazines-1, 4Oxazines-1, 4 hydrogénées condensés avec des carbocycles condensés avec un cycle à six chaînons
  • A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
  • A61P 35/00 - Agents anticancéreux
  • A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
  • C07C 1/00 - Préparation d'hydrocarbures à partir d'un ou plusieurs composés, aucun d'eux n'étant un hydrocarbure
  • C07D 209/08 - IndolesIndoles hydrogénés avec uniquement des atomes d'hydrogène ou des radicaux ne contenant que des atomes d'hydrogène et de carbone, liés directement aux atomes de carbone de l'hétérocycle
  • C07D 217/16 - Composés hétérocycliques contenant les systèmes cycliques de l'isoquinoléine ou de l'isoquinoléine hydrogénée avec des radicaux, substitués par des hétéro-atomes, liés aux atomes de carbone du cycle contenant l'azote autres que des radicaux aralkyle substitués par des atomes d'oxygène
  • C07D 307/85 - Atomes de carbone comportant trois liaisons à des hétéro-atomes avec au plus une liaison à un halogène liés en position 2
  • C07D 311/24 - Benzo [b] pyrannes non hydrogénés dans le carbocycle avec des atomes d'oxygène ou de soufre liés directement en position 4 avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement en position 2
  • C07D 311/68 - Benzo [b] pyrannes non hydrogénés dans le carbocycle avec des substituants autres que des atomes d'oxygène ou de soufre en position 2 ou 4 avec des atomes d'azote liés directement en position 4
  • C07D 317/68 - Atomes de carbone comportant trois liaisons à des hétéro-atomes avec au plus une liaison à un halogène
  • C07D 319/20 - Dioxanes-1, 4Dioxanes-1, 4 hydrogénés condensés avec des carbocycles ou avec des systèmes carbocycliques condensés avec un cycle à six chaînons avec des substituants liés à l'hétérocycle
  • C07D 405/12 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 405/14 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
  • C07D 413/06 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes d'azote et d'oxygène comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne carbonée contenant uniquement des atomes de carbone aliphatiques